Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The frequency of antibodies against cyclic citrullinated peptides and rheumatoid factor in healthy population: a field study of rheumatoid arthritis from northern Turkey.

Tasliyurt T, Kisacik B, Kaya SU, Yildirim B, Pehlivan Y, Kutluturk F, Ozyurt H, Sahin S, Onat AM.

Rheumatol Int. 2013 Apr;33(4):939-42. doi: 10.1007/s00296-012-2458-5. Epub 2012 Jul 25.

PMID:
22829412
2.

Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.

Uçar F, Çapkin E, Karkucak M, Yücel B, Sönmez M, Alver A, Kaklikkaya N, Tosun M, Alemdaroğlu E, Solak M.

Int J Rheum Dis. 2012 Dec;15(6):538-45. doi: 10.1111/j.1756-185X.2011.01604.x. Epub 2011 Mar 4.

PMID:
23253237
3.

Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.

Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.

J Rheumatol. 2006 Dec;33(12):2390-7. Epub 2006 Aug 15.

PMID:
16924694
4.

Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.

Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.

J Rheumatol. 2009 Apr;36(4):712-6. doi: 10.3899/jrheum.080653. Epub 2009 Mar 13.

PMID:
19286846
5.

[The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].

Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.

Mikrobiyol Bul. 2008 Oct;42(4):669-74. Turkish.

PMID:
19149089
6.

Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.

Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.

Arthritis Rheum. 2006 Feb 15;55(1):53-6.

7.
8.
9.

Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.

Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA.

J Rheumatol. 2002 Oct;29(10):2074-6.

PMID:
12375314
10.

Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis.

Itty S, Pulido JS, Bakri SJ, Baratz KH, Matteson EL, Hodge DO.

Trans Am Ophthalmol Soc. 2008;106:75-81; discussion 81-3.

12.

Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia.

Liu FC, Chao YC, Hou TY, Chen HC, Shyu RY, Hsieh TY, Chen CH, Chang DM, Lai JH.

Clin Rheumatol. 2008 Apr;27(4):463-7. Epub 2007 Sep 18.

PMID:
17876647
13.

The prevalence of rheumatoid factor isotypes and anti-cyclic citrullinated peptides in Malaysian rheumatoid arthritis patients.

Gomez EL, Gun SC, Somnath SD, D'Souza B, Lim AL, Chinna K, Radhakrishnan AK.

Int J Rheum Dis. 2011 Feb;14(1):12-7. doi: 10.1111/j.1756-185X.2010.01573.x. Epub 2010 Oct 26.

PMID:
21303477
14.

Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.

Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.

J Rheumatol. 2004 Sep;31(9):1829-33.

PMID:
15338508
15.

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ.

Arthritis Rheum. 2003 Oct;48(10):2741-9.

16.

The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.

Ryu HJ, Takeuchi F, Kuwata S, Kim YJ, Lee EY, Lee EB, Song YW.

Rheumatol Int. 2011 Mar;31(3):315-9. doi: 10.1007/s00296-009-1260-5. Epub 2009 Dec 15.

PMID:
20012964
18.

Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.

Kamali S, Polat NG, Kasapoglu E, Gul A, Ocal L, Aral O, Konice M, Badur S, Inanc M.

Clin Rheumatol. 2005 Nov;24(6):673-6. Epub 2005 May 31.

PMID:
15926038
19.

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ.

Arthritis Rheum. 2000 Jan;43(1):155-63.

20.

The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.

da Mota LM, Dos Santos Neto LL, de Carvalho JF, Pereira IA, Burlingame R, Ménard HA, Laurindo IM.

Rheumatol Int. 2012 Dec;32(12):3807-12. doi: 10.1007/s00296-011-2260-9. Epub 2011 Dec 21.

PMID:
22187055

Supplemental Content

Support Center